Tenon Medical price to book ratio TNON
Market value divided by the book value of the company's net assets, since 2022.
- Today, Nov 2, 2026
- n/m
- not a meaningful number
- Last meaningful
- 0.6×
- Aug 2026
- 4-year median
- 1.5×
- 4-year range
- 0.4× to 8.0×
- Peer median
- 0.2×
Tenon Medical's price to book ratio is not a meaningful number today: shareholders' equity was zero, negative or not reported, so price to book does not exist.
It was last meaningful in Aug 2026, at 0.6×.
On the days it had one over the last 4 years, its median was 1.5×, from 0.4× in Mar 2025 to 8.0× in May 2023.
Price to book ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 0.6× | 0.6× | 3.3× |
| 2025 | 1.9× | 0.4× | 2.3× |
| 2024 | 0.7× | 0.6× | 4.5× |
| 2023 | 1.6× | 1.1× | 8.0× |
| 2022 | 1.4× | 0.9× | 2.1× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Tenon Medical's size, closest first, today.
| Company | Price to book ratio |
|---|---|
| TNONTenon Medical | n/m |
| BBLGBone Biologics | 0.2× |
| IVFINVO Fertility | 0.1× |
| AMIXAutonomix Medical | 0.5× |
| NXGLNexgel | 0.4× |
| ADGMAdagio Medical | n/m |
| VJETFlyte Aviation | 0.0× |
| XAIRBeyond Air | 1.1× |
| VVOSVivos Therapeutics | n/m |
| CODXCo-Diagnostics | 0.2× |
| BJDXBluejay Diagnostics | 0.1× |
| Peer median | 0.2× |
What the price to book ratio tells you
Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.
Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.
More on Tenon Medical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.